Published by Benjamin Chiou on 20th June 2025
(Sharecast News) - Japanese regulators have accepted GSK's application to expand the use of its RSV vaccine, Arexvy, to the entire adult population.
URL: http://www.digitallook.com/dl/news/story/35163051/...